Key points are not available for this paper at this time.
The Feminization of HPV: Reversing Gender Biases in US Human Papillomavirus Vaccine Policy Affiliation Ellen M. Daley PhD, MPH, Cheryl A. Vamos PhD, MPH, Gregory D. Zimet PhD, HSPP, Zeev Rosberger PhD, MA, Erika L. Thompson PhD, MPH, and Laura Merrell MPHEllen M. Daley, Cheryl Vamos, Erika Thompson, and Laura Merrell are with the Department of Community and Family Health, University of South Florida, College of Public Health, Tampa. Gregory Zimet is with the Department of Adolescent Medicine, Indiana University, College of Medicine, Indianapolis. Zeev Rosberger is with the Department of Oncology, McGill University, College of Medicine, Montreal, Quebec, Canada.CopyRightCorrespondence should be sent to Ellen M. Daley, Professor, Department of Community and Family Health, College of Public Health, University of South Florida, 13201 Bruce B. Downs Blvd. MDC 56. Tampa, FL, 33612 (e-mail: email protectedusf.edu). Reprints can be ordered at http://www.ajph.org by clicking the “Reprints” link.CONTRIBUTORSAll contributors equally to the writing of this editorial. https://doi.org/10.2105/AJPH.2016.303122 Accepted: February 04, 2016 Published Online: May 06, 2016
Daley et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: